Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma

Haematologica

Volumn 92, Issue 11, 2007, Pages 1513-1518

  Gahrton, Gösta ^a   Iacobelli, Simona ^b   Bandini, Giuseppe ^c   Björkstrand, Bo ^a   Corradini, Paolo ^d   Crawley, Charles ^e   Hegenbart, Ute ^f   Morgan, Gareth ^g   Kröger, Nicolaus ⁱ   Schattenberg, Anton ^k   Schönland, Stefan O ^f   Verdonck, Leo F ^h   Volin, Lisa ^j   De Witte, Theo ^k   Niederwieser, Dietger ^l  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF LEIPZIG   (Germany)

more..

Author keywords

Bone marrow trasplantation; Multiple myeloma; Myeloablative conditioning; Peripheral blood stem cell trasplantation; Reduced intensity conditioning

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; LYMPHOCYTE ANTIBODY; MELPHALAN; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; RELAPSE; SIBLING; SURVIVAL RATE; T CELL DEPLETION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HISTOCOMPATIBILITY; HUMANS; INFANT; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; SIBLINGS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 36349017233     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11353     Document Type: Article

References (17)

1. Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Björkstrand B, et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-8 at European Group for Blood and Marrow Transplantation centres. The European Group for Blood and Marrow Transplantation. Br J Haematol 2001;113:209-16.
2. Mahmoud H, Fahmy O, Kamel A, Kamel M, El-Haddad A, El-Kadi D. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 1999;24:355-8.
3. Vigorito AC, Azevedo WM, Marques JF, Azevedo AM, Eid KA, Aranha FJ, et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998; 22:1145-51.
4. Heldal D, Tjonnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000;25:1129-36.
5. Powles R, Mehta J, Kulkarni S, Treleaven J, Millar B, Marsden J, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355:1231-7.
6. Blaise D, Kuentz M, Fortanier C, Bourhis JH, Milpied N, Sutton L, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 2000;18:537-46.
7. Vigorito AC, Marques Junior JF, Aranha FJ, Oliveira GB, Miranda EC, et al. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update. Haematologica 2001; 86:665-6.
8. Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001;98:3186-91.
9. Schmitz N, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, et al. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Haematologica 2005;90:643-8.
10. Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, et al. Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. Biol Blood Marrow Transplant 2005;11:85-92.
11. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001;344:175-81.
12. Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Canadian Bone Marrow Transplant Group. Blood 2002;100:1525-31.
13. Cornelissen JJ, van der Holt B, Petersen EJ, Vindelov L, Russel CA, Höglund M, et al. A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies. Exp Hematol 2003;31:855-64.
14. Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood 2003;102:3447-54.
15. Crawley C, Lalancette M, Szydlo R, Gilleece M, Peggs K, Mackinnon S, et al. Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. Chromic Leukaemia Working Party of the EBMT. Blood 2005;105:4532-9.
16. Crawley C, Iacobelli I, Björkstrand B, Apperley J, Niederwieser D, Gahrton G. Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning. Blood 2007;109:3588-94.
17. Stem Cell Trialists'Collaborating Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005;23:5074-87.